𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

✍ Scribed by David Eveleth, Carla Starita, Charles Tressler


Book ID
119897724
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
221 KB
Volume
12
Category
Article
ISSN
1471-2415

No coin nor oath required. For personal study only.